Appeal No. 95-2022 Application No. 08/063,056 its fairness is evidenced by the PTO's inability to manufacture products or to obtain and compare prior art products. [Footnote and citations omitted.] On these facts, we believe that the burden of persuasion shifted to appellants "to prove that the prior art products do not necessarily or inherently possess the characteristics of [their] claimed product." This appellants have not done. In the absence of a showing, it appears that the evaporated black liquor described by Forss, EXAMPLE 10, like the product defined in claims 31 and 32, comprises molecules which pass through an ultrafiltration membrane having a molecular weight cut-off of about 50,000 and are rejected by an ultrafiltration membrane having a molecular weight cut-off of about 2,000. For these reasons, we find that (1) the examiner established a prima facie case of anticipation of claims 31 and 32 based on the description in Forss, EXAMPLE 10; and (2) appellants have not rebutted the prima facie case. We therefore affirm the rejection of independent claims 31 and 32 under 35 U.S.C. § 102(b) as anticipated by Forss. In so doing, we are mindful that appellants rely on data presented in their specification and in the McVay declaration, executed July 12, 1993, designed to show that their claimed product possesses unexpectedly superior results. See the Appeal Brief, section VI.C. We point out, however, that a proper rejection under 35 U.S.C. § 102 cannot be -4-Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007